Parameter | SVR patients (n = 12) | Non-responders (n = 10) | Statistical significance | |
---|---|---|---|---|
Gender (M/F) | 6/6 | 6/4 | NS | |
Age (yr)a | 46.3 ± 18.7 | 46.8 ± 12.8 | NS | |
Baseline viral load (IU/ml) | 1.33 × 106 ± 1.28 × 106 | 1.04 × 106 ± 1.14 × 106 | NS | |
Serum ALT activity (U/L) | 94.1 ± 79.9 | 96.4 ± 50.3 | NS | |
Grading | 2.42 ± 0.16 | 1.92 ± 0.17 | P = 0.029 | |
Staging | 2.54 ± 0.23 | 1.88 ± 0.14 | P = 0.053 | |
IL28B genotype | CC | 7 | 0 | P = 0.005 |
CT | 3 | 7 | ||
TT | 2 | 3 | ||
Genotype | 1b | 7 | 8 | NS |
3a | 4 | 1 | ||
4 | 1 | 1 | ||
Complianceb | 8 (66 %) | 7 (70 %) | ||
Leukocytes (109/L) | 5.95 ± 2.22 | 5.80 ± 1.95 | ||
Neutrophils (109/L) | 3.28 ± 1.51 | 3.11 ± 1.32 |